[Clostridium] paradoxum Details: NCBI 29346, gram-negative or unknown [species]

| [Clostridium] paradoxum| ATCC 51510| CIP 105527| Clostridium paradoxum| Clostridium paradoxum Li et al. 1993| DSM 7308| strain JW-YL-7

  1. Gut microbiota: Clostridium species are common members of the human gut microbiota, where they play important roles in fermentation, metabolism, and immune regulation. While some Clostridium species are considered beneficial and contribute to gut health, others may be opportunistic pathogens under certain conditions. Clostridium paradoxum has been detected in the human gut microbiota, but its specific role in gut health and disease is not well understood.

  2. Disease association: While Clostridium paradoxum is not commonly associated with human disease, some Clostridium species are known to cause infections in humans, particularly in individuals with underlying health conditions or compromised immune systems. Clostridium difficile, for example, is a well-known pathogen that can cause antibiotic-associated diarrhea and pseudomembranous colitis. Clostridium botulinum produces botulinum toxin, which can cause botulism, a severe and potentially life-threatening illness.

  3. Production of metabolites: Clostridium species are capable of producing a wide range of metabolites, including short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate, as well as various toxins and enzymes. These metabolites can have diverse effects on host physiology, immune function, and gut barrier integrity. While some metabolites produced by Clostridium species may be beneficial, others may be harmful and contribute to disease development.

  4. Opportunistic infections: Clostridium species, including Clostridium paradoxum, have been implicated in opportunistic infections, particularly in healthcare settings. Infections with Clostridium species can occur following surgical procedures, invasive medical interventions, or prolonged antibiotic therapy. Clostridium difficile infections, in particular, have become a significant public health concern due to the emergence of antibiotic-resistant strains and the associated morbidity and mortality.

  5. Potential probiotic properties: While most research on Clostridium species has focused on their pathogenic potential, some strains may have probiotic properties and could be beneficial for gut health. Clostridium species capable of producing SCFAs, such as butyrate, may have anti-inflammatory and immunomodulatory effects in the gut. However, further research is needed to evaluate the safety and efficacy of Clostridium-based probiotics for human use.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for [Clostridium] paradoxum

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 0.09 10 20 1 29 15 15 7.1 10 20 25 %ile 50 %ile
biomesight 50.38 0 50 10 990 0 2839 218.6 70 1337.2 0 250 3.3 %ile 97.2 %ile
thryve 58.48 0 34 18 79 0 258 62.9 37 99.3 9 89 11.2 %ile 91.2 %ile

External Reference Ranges for [Clostridium] paradoxum

[Clostridium] paradoxum (NCBI 29346) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for [Clostridium] paradoxum
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
BiomeSight 53.171 %   0.019 %  0.071 % 1576.0 2964
BiomeSightRdp 6.452 %   0.002 %  0.001 % 2.0 31
Thryve 60.36 %   0.006 %  0.009 % 839.0 1390

To see medical conditions associated you may be logged in

And display level must be raised above public.


This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.